These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17270051)

  • 1. Closing the access gap for health innovations: an open licensing proposal for universities.
    Chaifetz S; Chokshi DA; Rajkumar R; Scales D; Benkler Y
    Global Health; 2007 Feb; 3():1. PubMed ID: 17270051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
    Crager SE; Guillen E; Price M
    Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global health equity in United Kingdom university research: a landscape of current policies and practices.
    Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
    Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of intellectual property rights in treatment access: challenges and solutions.
    't Hoen E; Passarelli CA
    Curr Opin HIV AIDS; 2013 Jan; 8(1):70-4. PubMed ID: 23201855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community health outreach program of the Chad-Cameroon petroleum development and pipeline project.
    Utzinger J; Wyss K; Moto DD; Tanner M; Singer BH
    Clin Occup Environ Med; 2004 Feb; 4(1):9-26. PubMed ID: 15043361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sponsored research agreements, university and government licensing, and clinical trial agreements: special contractual and intellectual property rights considerations.
    Somers JP
    J Biolaw Bus; 2003; 6(4):5-13. PubMed ID: 15072054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poverty, health & intellectual property rights with special reference to India.
    Satyanarayana K; Srivastava S
    Indian J Med Res; 2007 Oct; 126(4):390-406. PubMed ID: 18032814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation.
    Cottingham J; Berer M
    Reprod Health Matters; 2011 Nov; 19(38):69-84. PubMed ID: 22118143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alma Ata and health for all by the year 2000. The roles of academic institutions.
    Bryant JH; Zuberi RW; Thaver IH
    Infect Dis Clin North Am; 1991 Jun; 5(2):403-16. PubMed ID: 1869817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.
    Kuek V; Phillips K; Kohler JC
    Glob Public Health; 2011; 6(2):111-24. PubMed ID: 20234967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of bilateral free trade agreements on access to medicines.
    Correa CM
    Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market-based licensing for HPV vaccines in developing countries.
    Outterson K; Kesselheim AS
    Health Aff (Millwood); 2008; 27(1):130-9. PubMed ID: 18180488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. University opposition to unfettered research: a new bedfellow for biotech?
    Record KL
    Health Matrix Clevel; 2012; 22(1):139-67. PubMed ID: 22616545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story.
    Gore C; Morin S; Røttingen JA; Kieny MP
    BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37669799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements.
    Griffen EJ; Boulet P; ;
    Wellcome Open Res; 2024; 9():374. PubMed ID: 39184131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.